rs191149379

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_203486.3(DLL3):​c.1562C>T​(p.Ser521Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00545 in 1,599,320 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0063 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 88 hom. )

Consequence

DLL3
NM_203486.3 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.322

Publications

0 publications found
Variant links:
Genes affected
DLL3 (HGNC:2909): (delta like canonical Notch ligand 3) This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DLL3 Gene-Disease associations (from GenCC):
  • spondylocostal dysostosis 1, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive spondylocostal dysostosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028181076).
BP6
Variant 19-39507507-C-T is Benign according to our data. Variant chr19-39507507-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 260776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00629 (958/152322) while in subpopulation NFE AF = 0.00526 (358/68028). AF 95% confidence interval is 0.00481. There are 12 homozygotes in GnomAd4. There are 616 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DLL3NM_203486.3 linkc.1562C>T p.Ser521Phe missense_variant Exon 7 of 9 ENST00000356433.10 NP_982353.1 Q9NYJ7-2
DLL3NM_016941.4 linkc.1562C>T p.Ser521Phe missense_variant Exon 7 of 8 NP_058637.1 Q9NYJ7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DLL3ENST00000356433.10 linkc.1562C>T p.Ser521Phe missense_variant Exon 7 of 9 2 NM_203486.3 ENSP00000348810.4 Q9NYJ7-2
DLL3ENST00000205143.4 linkc.1562C>T p.Ser521Phe missense_variant Exon 7 of 8 1 ENSP00000205143.3 Q9NYJ7-1
DLL3ENST00000596614.5 linkc.*218C>T downstream_gene_variant 2 ENSP00000471688.1 M0R177

Frequencies

GnomAD3 genomes
AF:
0.00629
AC:
958
AN:
152204
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0511
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00526
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00749
AC:
1592
AN:
212480
AF XY:
0.00713
show subpopulations
Gnomad AFR exome
AF:
0.000174
Gnomad AMR exome
AF:
0.000699
Gnomad ASJ exome
AF:
0.00118
Gnomad EAS exome
AF:
0.0000631
Gnomad FIN exome
AF:
0.0544
Gnomad NFE exome
AF:
0.00511
Gnomad OTH exome
AF:
0.00653
GnomAD4 exome
AF:
0.00537
AC:
7764
AN:
1446998
Hom.:
88
Cov.:
31
AF XY:
0.00525
AC XY:
3776
AN XY:
718758
show subpopulations
African (AFR)
AF:
0.000392
AC:
13
AN:
33126
American (AMR)
AF:
0.000658
AC:
28
AN:
42556
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
30
AN:
25782
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38748
South Asian (SAS)
AF:
0.00146
AC:
123
AN:
84100
European-Finnish (FIN)
AF:
0.0534
AC:
2726
AN:
51050
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5752
European-Non Finnish (NFE)
AF:
0.00411
AC:
4542
AN:
1106124
Other (OTH)
AF:
0.00499
AC:
298
AN:
59760
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
520
1040
1560
2080
2600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00629
AC:
958
AN:
152322
Hom.:
12
Cov.:
32
AF XY:
0.00827
AC XY:
616
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41572
American (AMR)
AF:
0.000915
AC:
14
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4828
European-Finnish (FIN)
AF:
0.0511
AC:
543
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00526
AC:
358
AN:
68028
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00508
Hom.:
2
Bravo
AF:
0.00230
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00255
AC:
20
ExAC
AF:
0.00598
AC:
711
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DLL3: BS2 -

Spondylocostal dysostosis 1, autosomal recessive Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Apr 05, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Syndactyly Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.30
.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.37
T;T
MetaRNN
Benign
0.0028
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
0.32
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-1.3
N;N
REVEL
Benign
0.17
Sift
Benign
0.10
T;T
Sift4G
Benign
0.15
T;T
Polyphen
0.044
.;B
Vest4
0.15
MVP
0.72
MPC
0.66
ClinPred
0.023
T
GERP RS
-1.1
Varity_R
0.084
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191149379; hg19: chr19-39998147; API